Shineyo Medical Named 'Most Promising Investment Enterprise of 2025' at Pudong Innovation & Entrepreneurship Conference
ShineyoMedical
Provider of Atrial Fibrillation Electrophysiology and Peripheral Vascular Intervention Solutions
Click the blue words to follow us
ENTERPRISE
20
25
SHINEYOMEDICAL
ShineyoMedical Honored
2025 Pudong Innovation and Entrepreneurship Conference
SHINEYOMEDICAL
Enterprise with the Most Investment Potential of the Year
December 15th, afternoon,2025 Pudong Innovation and Entrepreneurship ConferenceSuccessfully held at the Zhangjiang Science Hall. The conference was hosted by relevant departments of the Pudong New Area, with leaders from the Shanghai Science and Technology Commission and district authorities in attendance. It showcased the achievements of Pudong's innovation and entrepreneurship ecosystem. Several important awards, such as "The Most Investment-Potential Enterprise of the Year," were presented during the event to support the cultivation of new productive forces and the construction of a science and technology innovation center.ShineyoMedicalShineyoMedical stands out with its excellent scientific and technological innovation capabilities and has been rated as a top enterprise in the Pudong New Area.Most Promising Investment Enterprise of 2025。
2025·CONGRATULATION
This year, an innovative product independently developed by ShineyoMedical ——ShineRhythm® Cardiac Pulsed Field Ablation SystemAndRhythPulse® Single-Use Cardiac Pulsed Field Ablation CatheterObtained the Class III Medical Device Registration Certificate issued by the National Medical Products Administration. With the launch of these two products, ShineyoMedical has achieved two breakthroughs in China's record —"China's First Large-Lesion Ablation Catheter" "China's First Unilateral Targeted Ablation Catheter", filling the technical gap in the field of cardiac pulsed electric field ablation in China.
Awarded this time"Company with the Most Investment Potential of the Year", which not only affirms ShineyoMedical's current innovation capabilities but also reflects the high importance placed by Pudong New Area on the growth potential of hard-tech enterprises. Looking ahead, ShineyoMedical will continue to prioritize technology research and development, expand its product portfolio and application scenarios, actively participate in and integrate into Pudong’s ecosystem of technological innovation and industrial integration, and contribute to the higher-quality development of the regional economy.
"Innovation Seeds" Thrive in Pudong
"Over the five years since the company was established, Pudong has given us a lot of support, both in terms of policy and platform building," said Shi Jiayi, Commercial Development Director at ShineyoMedical. Currently, the company has more than 10 products under development across its two research pipelines, with four products expected to be approved for market launch in the first quarter of next year.
1215
【ShineyoMedical RhythPulse®-PFA System】
ShineyoMedical's RhythPulse®-PFA System is the first approved Pulse Field Ablation (PFA) system in China that integrates multi-channel, large focal, and targeted ablation, mainly used for treating rapid arrhythmias such as drug-refractory and recurrent atrial fibrillation. Its core advantages include:
Large Focal Spot Design:Using the world's first 10mm ring ablation catheter, a single discharge can cover a lesion area with a diameter of 10mm, increasing the ablation efficiency more than three times compared to traditional technology.
Targeted Ablation Technology:Equipped with an intelligent contact detection module, it monitors the contact status between the electrode and myocardial tissue in real time, reducing the risk of hemolysis caused by ineffective discharges, and decreasing postoperative plasma free hemoglobin levels by 50%.
Excellent Clinical Validation:In the clinical trial of 151 cases, the immediate success rate was 100%, and the success rate for atrial fibrillation treatment at 12 months post-operation reached 85.07%, achieving internationally leading standards.
2025·CONGRATULATION
WeChat ID丨ShineyoMedical
Official Website丨shineyomedical.com